Sigachi Laboratories Limited

Produces pharmaceutical products and offers financial services.

1994 | Active
Last Updated: January 10, 2025

Sigachi Laboratories Profile

Key Indicators

  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 6.75 Cr
  • Company Age 30 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.10 Cr
  • Revenue Growth -21.24%
  • Profit Growth -27.51%
  • Ebitda -28.08%
  • Net Worth 11.11%
  • Total Assets 10.59%

About Sigachi Laboratories

Sigachi Laboratories Limited (SLL) is a Public Limited Indian Non-Government Company incorporated in India on 21 November 1994 and has a history of 30 years and three months. Its registered office is in Na, Telangana.

The Company is engaged in the Financial Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 6.75 Cr.

The company currently has active open charges totaling ₹1.10 Cr.

The Key Managerial Personnel (KMP) at Sigachi Laboratories Limited India are Boina Kumar as CFO and Lekha Surapaneni as Company Secretary. Adinarayana Tunuguntla, Sridevi Madati, Rajasekhar Tunuguntla, and Four other members serve as directors at the Company.

Company Details

  • Location Na, Telangana
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    slllab.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    L24230TG1994PLC018786

  • Company No.

    018786

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    21 Nov 1994

  • Date of AGM

    09 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Hyderabad

Industry

Financial Services
Pharma

Who are the key members and board of directors at Sigachi Laboratories?

Executive Team (2)

NameDesignationAppointment DateStatus
Boina Kumar Country flag representing In CFO01-Oct-2014Current
Lekha Surapaneni Country flag representing In Company Secretary11-Mar-2020Current

Board Members (7)

NameDesignationAppointment DateStatus
Adinarayana Tunuguntla Country flag representing In Director 01-Jul-2008Current
Sridevi Madati Country flag representing In Director 24-Sep-2021Current
Rajasekhar Tunuguntla Country flag representing In Whole-Time Director 30-Jan-2010Current
Tadepalli Govardhana Country flag representing In Director 30-Mar-2015Current
Shilpa Bung Country flag representing In Director 10-Feb-2021Current
Gurram Mohanrao Country flag representing In Director 27-Sep-2019Current

Financial Performance of Sigachi Laboratories.

Sigachi Laboratories Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.24% decrease. The company also saw a substantial fall in profitability, with a 27.51% decrease in profit. The company's net worth Soared by an impressive increase of 11.11%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-21.24%
Revenue from Operations
-25.29%
Total Assets
10.59%
Profit or Loss
-27.51%
Net Worth
11.11%
EBITDA
-28.08%

What is the Ownership and Shareholding Structure of Sigachi Laboratories?

In 2023, Sigachi Laboratories had a promoter holding of 36.86% and a public holding of 63.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.10 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Teh Benbares State Bank Ltd. : 1.10 Cr

Latest Charge Details

DateLenderAmountStatus
06 Dec 1997Teh Benbares State Bank Ltd.₹1.10 CrOpen

How Many Employees Work at Sigachi Laboratories?

Unlock and access historical data on people associated with Sigachi Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sigachi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigachi Laboratories's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sigachi Laboratories

Recent activity within the organization

  • Annual General Meeting

    Sigachi Laboratories Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records.

    09 Sep 2024

  • Balance Sheet

    Sigachi Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

    31 Mar 2024

  • Director Appointment

    China Sai Babu Puppala was appointed as a Director was appointed as a Director on 27 Sep 2023 & has been associated with this company since 1 year 4 months .

    27 Sep 2023

  • Director Appointment

    Sridevi Madati was appointed as a Director was appointed as a Director on 24 Sep 2021 & has been associated with this company since 3 years 4 months .

    24 Sep 2021

  • Director Appointment

    Shilpa Bung was appointed as a Director was appointed as a Director on 10 Feb 2021 & has been associated with this company since 4 years 11 days .

    10 Feb 2021

  • Director Appointment

    Lekha Sai Surapaneni was appointed as a Company Secretary was appointed as a Company Secretary on 11 Mar 2020 & has been associated with this company since 4 years 11 months .

    11 Mar 2020

Frequently asked questions

  • Sigachi Laboratories Limited was incorporated on 21 Nov 1994.

  • The authorized share capital of Sigachi Laboratories Limited is ₹ 12.00 Cr and paid-up capital is ₹ 6.75 Cr.

  • Currently 9 directors are associated with Sigachi Laboratories Limited.

    • Adinarayana Tunuguntla
    • Sridevi Madati
    • Rajasekhar Tunuguntla
    • Tadepalli Rao Govardhana
    • Shilpa Bung
    • Gurram Mohanrao
    • China Sai Babu Puppala
    • Boina Kumar
    • Lekha Sai Surapaneni
  • As per Ministry of Corporate Affairs (Mca), the registered address of Sigachi Laboratories Limited is Sy.No.530 534 Temple Road Bonthapally Village Jinram Mandal Medak Dist, Telanga India, Na, Telangana.

  • The corporate identification number (CIN) of Sigachi Laboratories Limited is L24230TG1994PLC018786 and the company number is 018786 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Sigachi Laboratories Limited is https://www.slllab.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Sigachi Laboratories Limited has fallen by -21.24%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Sigachi Laboratories Limited has experienced an upsurge of 11.11%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Sigachi Laboratories Limited amount to ₹ 1.10 Cr.

  • The most recent Balance Sheet for Sigachi Laboratories Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development